BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34272396)

  • 1. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer.
    Li LY; Yang Q; Jiang YY; Yang W; Jiang Y; Li X; Hazawa M; Zhou B; Huang GW; Xu XE; Gery S; Zhang Y; Ding LW; Ho AS; Zumsteg ZS; Wang MR; Fullwood MJ; Freedland SJ; Meltzer SJ; Xu LY; Li EM; Koeffler HP; Lin DC
    Nat Commun; 2021 Jul; 12(1):4362. PubMed ID: 34272396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
    Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
    Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.
    Ma S; Zhou B; Yang Q; Pan Y; Yang W; Freedland SJ; Ding LW; Freeman MR; Breunig JJ; Bhowmick NA; Pan J; Koeffler HP; Lin DC
    Cancer Res; 2021 Mar; 81(5):1216-1229. PubMed ID: 33402390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
    Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
    Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.
    Huang Y; Yang Q; Zheng Y; Lin L; Xu X; Xu XE; Silva TC; Hazawa M; Peng L; Cao H; Ding Y; Lu D; Berman BP; Xu LY; Li EM; Yin D
    Nucleic Acids Res; 2021 Sep; 49(16):9246-9263. PubMed ID: 34370013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma.
    Hegde GV; de la Cruz C; Giltnane JM; Crocker L; Venkatanarayan A; Schaefer G; Dunlap D; Hoeck JD; Piskol R; Gnad F; Modrusan Z; de Sauvage FJ; Siebel CW; Jackson EL
    Elife; 2019 May; 8():. PubMed ID: 31144617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
    Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
    Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
    Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
    Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
    Chen L; Huang M; Plummer J; Pan J; Jiang YY; Yang Q; Silva TC; Gull N; Chen S; Ding LW; An O; Yang H; Cheng Y; Said JW; Doan N; Dinjens WN; Waters KM; Tuli R; Gayther SA; Klempner SJ; Berman BP; Meltzer SJ; Lin DC; Koeffler HP
    Gut; 2020 Apr; 69(4):630-640. PubMed ID: 31409603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.
    Zhang GC; Yu XN; Guo HY; Sun JL; Liu ZY; Zhu JM; Liu TT; Dong L; Shen XZ; Yin J
    Cancer Res; 2023 Feb; 83(4):521-537. PubMed ID: 36723974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis.
    Wang F; Liu X; Yang P; Guo L; Liu C; Li H; Long S; Shen Y; Wan H
    Cell Death Dis; 2014 Mar; 5(3):e1133. PubMed ID: 24651436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
    Zhou Y; Sinha S; Schwartz JL; Adami GR
    BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
    Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
    J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
    Gallant-Behm CL; Espinosa JM
    Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
    Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.